ADX10059 Completed Phase 2 Trials for Gastroesophageal Reflux Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00820079 | ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD) | |
| NCT00810485 | ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) |